AURA
Aura Biosciences Inc
NASDAQ: AURA · HEALTHCARE · BIOTECHNOLOGY
$7.05
+4.75% today
Updated 2026-04-30
Market cap
$432.06M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.76
Dividend yield
—
52W range
$4 – $8
Volume
0.3M
Aura Biosciences Inc (AURA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $37.05M | $22.10M | $160.03M | $223.94M | $255.07M | $182.50M |
| Cash & equivalents | $32.47M | $17.39M | $149.06M | $121.58M | $41.06M | $31.69M |
| Current assets | $33.35M | $18.45M | $153.70M | $196.70M | $231.79M | $160.62M |
| Total liabilities | $6.29M | $2.74M | $7.71M | $28.35M | $29.23M | $30.53M |
| Current liabilities | $6.15M | $2.66M | $7.36M | $10.46M | $12.36M | $14.91M |
| Long-term debt | $49000.00 | — | — | — | — | — |
| Shareholder equity | $30.76M | $19.36M | $152.31M | $195.58M | $225.85M | $151.97M |
| Retained earnings | $-94.68M | $-116.89M | $-152.14M | $-210.90M | $-287.31M | $-374.23M |
| Accounts receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — |